Microdeletion of Chromosome 15q11.2: Implications for Rare Diseases - Rare Disease

More Info

---

Understanding the implications of a microdeletion on chromosome 15q11.2 is crucial, especially given its association with various rare diseases. The specific region you mentioned, which spans approximately 520 kb, is known to harbor several important genes, including TUBGCP5, CYFIP1, NIPA1, and NIPA2. These genes are involved in various cellular functions, and their deletion can lead to a range of developmental and neurological disorders.

Microdeletions in this region are often linked to conditions such as Prader-Willi syndrome and Angelman syndrome, both of which can result in significant developmental challenges. The presence of a microdeletion can lead to a spectrum of symptoms, including intellectual disability, developmental delays, and behavioral issues. The severity of these symptoms can vary widely among individuals, even within the same family.

Regarding your question about the necessity of considering termination of pregnancy (引產), this is a deeply personal decision and should be approached with careful consideration and counseling. If the microdeletion is confirmed and is likely to lead to significant health issues, parents may face difficult choices. However, it is essential to have a comprehensive discussion with a genetic counselor or a medical geneticist who can provide insights based on the specific deletion, its implications, and the potential outcomes for the child.

If the microdeletion is inherited from one or both parents, the recurrence risk in future pregnancies may be higher, depending on the inheritance pattern of the genes involved. For instance, if one parent is a carrier of a pathogenic variant that leads to the deletion, there may be a 50% chance of passing it on to each child. Genetic counseling can help clarify these risks and provide guidance on family planning.

In terms of the pathogenicity of the deletion, research indicates that not all microdeletions are equally harmful. Some may be benign and not lead to any significant health issues, while others can have profound effects. The clinical significance often depends on the specific genes involved and their roles in development and health.

It is also worth noting that the absence of symptoms in parents does not rule out the possibility of them being carriers of a microdeletion. Genetic testing for both parents can provide valuable information about the inheritance pattern and potential risks for future children.

In summary, the implications of a microdeletion at chromosome 15q11.2 can be significant, and the decision regarding pregnancy should be made with thorough understanding and support from healthcare professionals. Genetic counseling is highly recommended to navigate these complex issues, assess risks, and discuss the potential for future pregnancies.